Analytical methods to manage potential impurities in drug substances |
Park, Kyung Min
(College of Pharmacy, Kyung Hee University)
Kim, Won Mi (College of Pharmacy, Kyung Hee University) Ahn, Su Hyun (College of Pharmacy, Kyung Hee University) Lee, Ha Lim (College of Pharmacy, Kyung Hee University) Hwang, Su Hyeon (College of Pharmacy, Kyung Hee University) Lee, Wonwoong (College of Pharmacy, Woosuk University) Hong, Jongki (College of Pharmacy, Kyung Hee University) |
1 | J. P. Guzowski Jr, C. Golanoski and E. R. Montgomery, J. Pharm. Biomed. Anal., 33, 963-974 (2003). DOI |
2 | M. Song, S. Wu, P.-b. Lu, Y.-n. Qiao and T.-j. Hang, Anal. Methods, 8, 8352-8361 (2016). DOI |
3 | T. Kumar, M. Ramya, V. Srinivasan and N. Xavier, J. Chromatogr. Sci., 55(7), 683-689 (2017). DOI |
4 | S. S. Kumar and R. K. Srivastava, Indian J. Pharm. Sci., 80(4), 744-749 (2018). |
5 | Z. Li, L. K. Jacobus, W. P. Wuelfing, M. Golden, G. P. Martin and R. A. Reed, J. Chromatogr. A, 1104, 1-10 (2006). DOI |
6 | J. Diekmann, C. Biefel and K. Rustemeier, J. Chromatogr. Sci., 40(9), 509-514 (2002). DOI |
7 | K. S. Sidhu, J. Appl. Polym. Sci., 1(6), 300-302 (1981). |
8 | J. L. Lunde, R. E. Nelson and H. F. Storandt, Pharmacotherapy, 27, 1202-1205 (2007). DOI |
9 | S. R. Reddy, K. H. Reddy, M. N. Kumar, P. M. Reddy, J. V. R. Reddy and H. K. Sharma, J. Chromatogr. Sci., 57(2), 101-107 (2019). DOI |
10 | S. Sleijfer, I. Ray-Coquard, Z. Papai, A. Le Cesne, M. Scurr, P. Schoffski, F. Collin, L. Pandite, S. Marreaud, A. De Brauwer, M. van Glabbeke, J. Verweij and J.-Y. Blay, Clin. J. Oncol. Nurs., 27, 3126-3132 (2009). DOI |
11 | IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, vol 7, Some Anti-Thyroid and Related Substances, Nitrofurans and Industrial Chemicals, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Anti-Thyroid-And-Related-Substances-Nitrofurans-And-Industrial-Chemicals-1974, Accessed 9 Sep 2021. |
12 | K. Hamada and H. Morishita, Sepctrosc. Lett., 13(6), 373-380 (1980). DOI |
13 | The National Institute for Occupational Safety and Health (NIOSH), Sodium Azide: Systemic Agent, https://www.cdc.gov/niosh/ershdb/emergencyresponsecard_29750027.html, Assessed 13 Aug 2021. |
14 | International Programme on Chemical Safety (IPCS), Concise International Chemical Assessment Document, https://inchem.org/documents/cicads/cicads/cicad42.htm., Accessed 15 Sep 2021. |
15 | J. P. Bercu, S. M. Galloway, P. Parris, A. Teasdale, M. Masuda-Herrera, K. Dobo, P. Heard, M. Kenyon, J. Nicolette, E. Vock, W. Ku, J. Harvey, A. White, S. Glowienke, E. A. Martin, L. Custer, R. A. Jolly and V. Thybaud, Regul. Toxicol. Pharmacol. 94, 172-182 (2018). DOI |
16 | 식품의약품안전처, 의약품 불순물 유전독성 평가 가이드라인 [민원인 안내서] 2017. 10., https://www.mfds.go.kr/brd/m_1060/view.do?seq=13434&srchFr=&srchTo=&srchWord=%EC%9D%98%EC%95%BD%ED%92%88+%EB%B6%88%EC%88%9C%EB%AC%BC+%EC%9C%A0%EC%A0%84%EB%8F%85%EC%84%B1+%ED%8F%89%EA%B0%80+%EA%B0%80%EC%9D%B4%EB%93%9C%EB%9D%BC%EC%9D%B8&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1, Assessed 2 Aug 2021. |
17 | N. Li and J. Zou, J. Appl. Polym. Sci., 100(4), 3141-3144 (2005). DOI |
18 | M. Maithani, R. Raturi, V. Gupta and P. Bansal, J. Liq. Chromatogr. Relat. Technol., 40(15), (2017). |
19 | D. Q. Liu, M. Sun and A. S. Kord, J. Pharm. Biomed. Anal., 51, 999-1014 (2010). DOI |
20 | M. Shelke, S. S. Deshpande and S. Sharma, Crit. Rev. Anal. Chem., 50(3), 226-253 (2020). DOI |
21 | European Medicines Agency, ICH guideline M7(R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk, https://www.ema.europa.eu/en/documents/scientific-guideline/ich-guideline-m7r1-assessment-control-dna-reactive-mutagenic-impurities-pharmaceuticals-limit_en.pdf, Assessed 2 Aug 2021. |
22 | Health Canada, Multiple lots of irbesartan, losartan and valsartan drugs recalled, https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715aeng.php, Assessed 13 Aug 2021. |
23 | 식품의약품안전처, [ICH Guideline] M7(R1) 잠재적 발암 위해를 제한하기 위한 의약품 중 DNA 반응성(변이원성) 불순물의 평가 및 관리, https://www.nifds.go.kr/brd/m_105/view.do?seq=30606&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=3, Assessed 30 Aug 2021. |
24 | C. W. Felix, Food Protection Technology, p29-37, CRC Press, Boca Raton, 1987. |
25 | I. C. Munro, A. G. Renwick and B. Danielewska-Nikiel, Toxicol. Lett., 180, 151-156 (2008). DOI |
26 | ICH, Guidelines M7 Mutagenic impurities, https://www.ich.org/page/multidisciplinary-guidelines, Assessed 2 Aug 2021. |
27 | N. Kumar and A. Jha, Saudi Pharm. J., 25, 176-183 (2017). DOI |
28 | L. Muller, R. J. Mauthe, C. M. Riley, M. M. Andino, D. De Antonis, C. Beels, J. De George, A. G. M. De Knaep, D. Ellison, J. A. Fagerland, R. Frank, B. Fritschel, S. Galloway, E. Harpur, C. D. N. Humfrey, A. S. Jacks, N. Jagota, J. Mackinnon, G. Mohan, D. K. Ness, M. R. O'Donovan, M. D. Smith, G. Vudathala and L. Yotti, Regul. Toxicol. Pharmacol., 44, 198-211 (2006). DOI |
29 | D. Jacobson-Kram and T. McGovern, Adv. Drug Deliv. Rev., 59, 38-42 (2007). DOI |
30 | M. Stare, K. Laniewski, A. Westermark, M. Sjogren and W. Tian, Org. Process. Res. Dev., 13, 857-862 (2009). DOI |
31 | Q. Yang, B. P. Haney, A. Vaux, D. A. Riley, L. Heidrich, P. He, P. Mason, A. Tehim, L. E. Fisher, H. Maag and N. G. Anderson, Org. Process. Res. Dev., 13(4), 786-791 (2009). DOI |
32 | IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 77, Some Industrial Chemicals, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Some-Industrial-Chemicals-2000, Accessed 4 Sep 2021. |
33 | A. Louie, Chem. Rev., 110, 3146-3195 (2010). DOI |
34 | E. U. Stolarczyk, K. Eksanow and K. Filip, Anal. Lett., 49(14), 2337-2346 (2016). DOI |
35 | IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol 71, Re-evaluation of Some Organic Chemicals, Hydrazine and Hydrogen Peroxide, https://publications.iarc.fr/Book-And-Report-Series/Iarc-Monographs-On-The-Identification-Of-Carcinogenic-Hazards-To-Humans/Re-evaluation-Of-Some-Organic-Chemicals-Hydrazine-And-Hydrogen-Peroxide-Part1-Part-2-Part-3--1999, Accessed 28 Sep 2021. |
36 | A. A. Ensafi and B. Rezaei, Talanta, 47, 645-649 (1998). DOI |
37 | Y.-Y. Liu, I. Schmeltz and D. Hoffmann, Anal. Chem., 46(7), 885-889 (1974). DOI |
38 | U. Balcik, D. S. Chormey, M. F. Ayyildiz and S. Bakirdere, Microchem. J., 155, 104712 (2020). DOI |
39 | T. Kaleemullah, M. Ahmed, H. K. Sharma, K. V. S. N. Raju and M. N. Kumar, Der Pharma Chem., 3(6), 390-399 (2011). |
40 | J.-G. Yim, H.-W. Jang and K.-G. Lee, Korean J. Food Sci. Technol., 42(3), 257-262 (2010). |
41 | M. G. Choi, J. O. Moon, J. Bae, J. W. Lee and S.-K. Chang, Org. Biomol. Chem., 11(18), 2961-2965 (2013). DOI |
42 | WMO. Scientific, Assessment of Ozone Depletion: 2006, https://csl.noaa.gov/assessments/ozone/2006/chapters/contentsprefaceexecutivesummary.pdf, Accessed 28 Sep 2021. |
43 | N. Yassaa, A. Wishkerman, F. Keppler and J. Williams, Environ. Chem., 6(4), 311-318 (2009). DOI |
44 | Y.-y. Zhao, Z.-z. Jing, H.-p. Li and H.-s. Zhang, Microchem. J., 69(3), 213 -217 (2001). DOI |
45 | H. H. W. Yang and A. Weisz, J. AOAC Int., 101(6), 1961-1966 (2018). DOI |
46 | T. Huang, M. E. Garceau and P. Gao, J. Pharm. Biomed. Anal., 31, 1203-1210 (2003). DOI |
47 | A. S. Ivanova, A. D. Merkuleva, S. V. Andreev and K. A. Sakharov, Food Chem., 283, 431-436 (2019). DOI |
48 | H. Yue, X. Bu, M.-H. Huang, J. Young and T. Raglione, Int. J. Pharm., 375, 33-40 (2009). DOI |
49 | K. Hori, N. Koriyama, H. Omori, M. Kuriyama, T. Arishima and K. Tsumura, Food Sci. Technol., 48, 204-208 (2012). |
50 | B. W. Manning, C. E. Cerniglia and T. W. Federlei, Appl. Environ. Microbiol., 50(1), 10-15 (1985). DOI |
51 | N. Rajana, D. V. Ramana, R. R. Ganta, D. R. Devi, A. A. Deshpande, J. M. Babu and K. Basavaiah, Sep. Sci. Plus, 3(10), 511-522 (2020). DOI |
52 | R. Peto, M. C. Pike, L. Bernstein, L. S. Gold and B. N. Ames, Environ. Health Perspect., 58, 1-8 (1984). DOI |
53 | A. Teasdale and D. P. Elder, Trends Anal. Chem., 101, 66-84 (2018). DOI |
54 | X. Zheng, W. Fu, K. Zheng, B. Gao, L. Lin, W. Liu, Z. Lin and Q. Fang, Food Control, 123, 107766 (2021). DOI |
55 | S. P. Felter, R. B. Conolly, J. P. Bercu, P. M. Bolger, A. R. Boobis, P. M. J. Bos, P. Carthew, N. G. Doerrer, J. I. Goodman, W. A. Harrouk, D. J. Kirkland, S. S. Lau, G. C. Llewellyn, R. J. Preston, R. Schoeny, A. R. Schnatter, A. Tritscher, F. van Velsen and G. M. Williams, Crit. Rev. Toxicol., 41(6), 507-544 (2011). DOI |
56 | Government of UK, Less than lifetime exposure: principles for consideration of risk, https://www.gov.uk/government/publications/less-than-lifetime-exposure-principles-for-consideration-of-risk, Assessed 31 Aug 2021. |
57 | B. Leblanc, C. Charuel, W. Ku and R. Ogilvie, Int. J. Pharm. Med., 18(4), 215-220 (2004). DOI |
58 | P. A. Harris, A. Boloor, M. Cheung, R. Kumar, R. M. Crosby, R. G. Davis-Ward, A. H. Epperly, K. W. Hinkle, R. N. Hunter III, J. H. Johnson, V. B. Knick, C. P. Laudeman, D. K. Luttrell, R. A. Mook, R. T. Nolte, S. K. Rudolph, J. R. Szewczyk, A. T. Truesdale, J. M. Veal, L. Wang and J. A. Stafford, J. Med. Chem., 51, 4632-4640 (2008). DOI |
59 | G. W. Aylward, Eye, 19, 1115-1118 (2005). DOI |
60 | F. David, K. Jacq, P. Sandra, A. Baker and M. S. Klee, Anal. Bioanal. Chem., 396, 1291-1300 (2010). DOI |
61 | H. G. Ramjit, M. M. Singh and A. B. Coddington, J. Mass Spectrom., 31(8), 867-872 (1996). DOI |
62 | K. Ramakrishna, N. V. V. S. S. Raman, K. M. V. N. Rao, A. V. S. S. Prasad and K. S. Reddy, J. Pharm. Biomed. Anal., 46, 780-783 (2008). DOI |
63 | P. R. Kakadiya, B. P. Reddy, V. Singh, S. Ganguly, T. G. Chandrashekhar and D. K. Singh, J. Pharm. Biomed. Anal., 55, 379-384 (2011). DOI |
64 | National Toxicology Program, Bioassay of p-Chloroaniline for possible carcinogenicity, https://ntp.niehs.nih.gov/publications/reports/tr/100s/tr189/index.html?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=tr189abs, Accessed 5 Oct 2021. |
65 | S. R. Khobare, V. Gajare, E. V. Reddy, R. Datrika, M. Banda, V. Siddaiah, S. S. Pachore, U. Timanna, V. H. Dahanukar and U. K. S. Kumar, Carbohydr. Res., 435, 1-6 (2016). DOI |
66 | Z. Y. Yuabova, D. R. Holschlag, S. A. Rodriguez, C. Qin, V. V. Papov, F. Qiu, J. F. McCaffrey and D. L. Norwood, J. Liq. Chromatogr. Relat. Technol., 31, 2318-2330 (2008). DOI |
67 | M. Gricar and S. Andrensek, J. Pharm. Biomed. Anal., 125, 27-32 (2016). DOI |
68 | A. Sturaro, G. Parvoli, L. Doretti, C. Bancomina and C. Neonato, Org. Mass Spectrom., 29(10), 575-577 (1994). DOI |
69 | W. Li, J. Chromatogr. A, 1046, 297-301 (2004). DOI |
70 | S. Chang and S. H. Lamm, Int. J. Toxicol., 22, 175-186 (2003). DOI |
71 | O. Wachelko, P. Szpotb and M. Zawadzki, J. Pharm. Biomed. Anal., 192, 113671 (2020). DOI |
72 | 식품의약품안전처, 고혈압치료제(사르탄류)와 금연 치료보조제(바레니클린) 안전성 조사 실시, https://www.mfds.go.kr/brd/m_99/view.do?seq=454744, Accessed 9 Sep 2021. |
73 | S. Fujimura, T. Sato and A. Watanabe, J. Antimicrob. Agents, 3(2), 1000138 (2017). |
74 | P. Aparna, S. V. Rao, K. M. Thomas, K. Mukkanti, P. B. Gupta, K. Rangarao, G. K. Narayan, T. Sandip and K. Upendra, Pharmazie, 65(5), 331-335 (2010). |
75 | H. Ono, K. Hisatani and K. Kamide, Polym. J., 25(3), 245-265 (1993). DOI |
76 | T. D. Ho, P. M. Yehl, N. P. Chetwyn, J. Wang, J. L. Anderson and Q. Zhong, J. Chromatogr. A, 1361, 217-228 (2014). DOI |
77 | D. C. Vu, T. L. Ho, P. H. Vo, G. Carlo, J. A. McElroy, A. N. Davis, S. C. Nagelg and C.-H. Lin, Anal. Methods, 10, 730-742 (2018). DOI |
78 | H. Hiratsuka, T. Okamoto, S. Kuroda, T. Okutsu, H. Maeoka, M. Taguchi and T. Yoshinaga, Res. Chem. Intermed., 27(1), 137-153 (2001). DOI |
79 | F. Bruner, G. Bertoni and C. Severini, Anal. Chem., 50(1), 53-55 (1978). DOI |
80 | V. M. Vorotyntsev, G. M. Mochalov, M. A. Kolotilova, and E. V. Volkova, J. Anal. Chem., 61(9), 883-888 (2006). DOI |
81 | M. A. Cardoso, M. L. D. Favero, J. C. Gasparetto, B. S. Hess, D. P. Stremel and R. Pontarolo, J. Liq. Chromatogr. Relat. Technol., 34, 1556-1567 (2015). |
82 | Z. Gajdosechova, Z. Mester and E. Pagliano, Anal. Chem. Acta, 1064, 40-46 (2019). DOI |
83 | E. Helms, N. Arpaia and M. Widener, J. Chem. Educ., 84(8), 1328-1330 (2007). DOI |
84 | 식품의약품안전처, LC-MS/MS를 이용한 사르탄류 원료의약품 중 AZBT 시험법, http://nifds.go.kr/brd/m_18/view.do?seq=12584&srchFr=&srchTo=&srchWord=&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=2, Accessed 9 Sep 2021. |
85 | W. J. Ehlhardt and J. J. Howbert, J. Pharmacol. Exp. Ther., 19(2), 366-369 (1990). |
86 | C. Chavis, C. De Gourcy and J.-L. Imbach, Carbohydr. Res., 135, 13-27 (1984). DOI |
87 | H. Wang, G. J. Provan and K. Helliwell, J. Pharm. Biomed. Anal., 29, 387-392 (2002). DOI |
88 | L. Homanen, Spectrochim. Acta Part A, 39(1), 77-84 (1983). DOI |
89 | M. E. Tuttolomondo, A. Navarro, T. Pena, E. L. Varetti and A. Ben Altabef, J. Phys. Chem. A, 109, 7946-7956 (2005). DOI |
90 | S. R. Reddy, K. H. Reddy, M. N. Kumar, P. M. Reddy, J. V. R. Reddy and H. K. Sharma, J. Chromatogr. Sci., 57(2), 101-107 (2019). DOI |
91 | X. Du, W. Zhang, B. Liu, T. Liu, Y. Xiao, M. Taniguchi and Y.L. Ren, J. AOAC Int., 102(6), 1877-1883 (2019). DOI |
92 | K. Hamada and H. Morishita, Sepctrosc. Lett., 13(6), 373-380 (1980). DOI |
93 | N. Sheppa, Trans. Faraday Soc., 46, 533-539 (1950). DOI |
94 | J. Forshed, B. Erlandsson and S. P. Jacobsson, Anal. Chim. Acta, 552, 160-165 (2005). DOI |
95 | C. C. Camarasu, J. Pharm. Biomed. Anal., 23, 197-210 (1998). DOI |
96 | R. J. Koopmans, R. Van Der Linden and E. F. Vansant, Polym. Eng. Sci., 22(14) 878-882 (1982). DOI |
97 | J. I. Bryant, J. Chem. Phys., 40(11), 3195-3203 (1964). DOI |
98 | R. L. Hudson and R. F. Ferrante, Mon. Notices Royal Astron. Soc., 492, 283-293 (2020). DOI |
99 | O. J. Kingsford, J. Qian, D. Zhang, Y. Yi and G. Zhu, Anal. Methods, 10(45), 5372-5379 (2018). DOI |
100 | J. Mitchell Jr and H. D. Deveraux, Anal. Chim. Acta, 100, 45-52 (1978). DOI |
101 | H. Below, N. Lehan and A. Kramer, Microchim. Acta, 146, 129-135 (2004). DOI |
102 | T. Platzek, C. Lang, G. Grohmann, U-S Gi. and W. Baltes, Hum. Exp. Toxicol., 18, 552-559 (1999). DOI |
103 | K. P. Evans, A. Mathias, N. Mellor, R. Silvester and A. E. Williams, Anal. Chem., 47(6), 821-824 (1975). DOI |
104 | J. Unwin and J. A. Groves, Anal. Chem., 68, 4489-4493 (1996). DOI |
105 | P. Otero, S. K. Saha, A. Hussein, J. Barron and P. Murray, Food Anal. Methods, 10(4), 876-884 (2017). DOI |
106 | M. Adosinda M. Martins, N. Lima, A. J. D. Silvestre and M. J. Queiroz, Chemosphere, 52, 967-973 (2003). DOI |
107 | European Medicines Agency, Assessment report, https://www.ema.europa.eu/en/documents/variation-report/angiotensin-ii-receptor-antagonists-sartans-article-31-referral-chmp-assessment-report_en.pdf, Assessed 13 Aug 2021. |
108 | Y.-J. Kang, M.-S. Kim, M.-T. Lee, S.-H. You, J.-E. Lee, J.-H. Eom and S.-Y. Jung, J. Pharmacoepidemiol. Risk Manag., 13(1), 10-16 (2021). DOI |
109 | International Labour Organization, https://www.ilo.org/dyn/icsc/showcard.listCards3, Accessed 1 Oct 2021. |
110 | The National Institute for Occupational Safety and Health (NIOSH), https://www.cdc.gov/niosh/npg/default.html, Accessed 1 Oct 2021. |
111 | P. Ellis, M. Kenyon and K. Dobo, Regul. Toxicol. Pharmacol., 65(2), 201-213 (2013). DOI |
112 | F. P. Guengerich, L. E. Geiger, L. L. Hogy and P. L. Wright, Cancer Res., 41, 4925-4933 (1981). |
113 | D. L. Vassilaros and T. J. Bzik, Environ. Sci. Technol., 25(5), 878-883 (1991). DOI |
114 | M. Shibata, K. Inoue, Y. Yoshimura, H. Nakazawa and Y. Seto, Arch. Toxicol., 78, 301-305 (2004). DOI |
115 | K. Ventura, A. Eisner and M. Adam, Cent. Eur. J. Public Health, 12, S86-S89 (2004). |
116 | R. P. Frost, M. S. Hussain and A. R. Raghani, J. Sep. Sci., 26, 1097-1103 (2003). DOI |
117 | J. V. Henshaw, LCGC North America, 29(10), 914-924 (2011). |
118 | R. S. Gable, Addiction, 99(6), 686-696 (2004). DOI |
119 | D. I. Robinson, Org. Process. Res. Dev., 14(4), 946-959 (2010). DOI |
120 | K. C. Giiven and T. Gezgin, Acta Pharm. Sci., 47, 15-20 (2005). |
121 | T. Kojima and Y. Tanaka, Anal. Chem., 48, 1760-1762 (1976). DOI |
122 | B. C. Ozkan, M. Firat, D. S. Chormey and S. Bakirdere, Microchem. J., 145, 84-89 (2019). DOI |
123 | C. F. Poole, J. Chromatogr. A, 1296, 15-24 (2013). DOI |
124 | C. C. Camarasu, M. Mezei-Szuts and G. B. Varga, J. Pharm. Biomed. Anal., 18, 623-638 (1998). DOI |
125 | A. Gosar, T. Shaikh, S. Botkondle, N. Mahadik and R. Tole. Int. J. Pharm. Res. Health Sci., 7(5), 3068-3071 (2019). DOI |
126 | M. Sun, L. Bai and D. Q. Liu, J. Pharm. Biomed. Anal., 49(2), 529-533 (2009). DOI |
127 | G.-P. Yang, X.-L. Lu, G.-S. Song and X.-M. Wang, Chinese J. Anal. Chem., 38(5), 719-722 (2010). DOI |
128 | X. Meng-Xia and L. Yuan, Spectrochim. Acta Part A, 58, 2817-2826 (2002). DOI |
129 | National Toxicology Program, Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride in F344/N Rats and B6C3F1 Mice (Gavage Studies), https://ntp.niehs.nih.gov/publications/reports/tr/300s/tr351/index.html?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=tr351abs, Accessed 5 Oct 2021. |
130 | J. S. Bus and J. A Popp, Food Chem. Toxicol., 25, 619-626 (1987). DOI |
131 | G. Szekely, M. C. A. De Sousa, M. Gil, F. C. Ferreira and W. Heggie, Chem. Rev., 115(16), 8182-8229 (2015). DOI |
132 | L. Havlikova, L. Matysova, L. Novakova, R. Hajkova and P. Solich, J. Pharm. Biomed. Anal., 43, 1169-1173 (2007). DOI |
133 | K. McAdam, H. Kimpton, S. Essen, P. Davis, C. Vas, C. Wright, A. Porter and B. Rodu, Chem. Cent. J., 9(13), (2015). |
134 | B. R. Basrani, S. Manek, D. Mathers, E. Fillery and R. N. S. Sodhi, J. Endod., 362, 312-314 (2010). |
135 | J. Zheng, W. A. Prittsa, S. Zhanga and S. Wittenbergerb, J. Pharm. Biomed. Anal., 50(5), 1054-1059 (2009). DOI |
136 | B. Tay Y. Ping and H. A. Aziz, J. Surfactants. Deterg., 22(4), 751-756 (2019). DOI |
137 | N. H. Petha, R. S. Lokhande, D. T. Seshadri and R. M. Patil, Microchem. J., 133, 506-509 (2017). DOI |